Cargando…
Rare diseases' genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project
Following the reverse genetics strategy developed in the 1980s to pioneer the identification of disease genes, genome(s) sequencing has opened the era of genomics medicine. The human genome project has led to an innumerable series of applications of omics sciences on global health, from which rare d...
Autores principales: | Ferlini, Alessandra, Gross, Edith Sky, Garnier, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548672/ https://www.ncbi.nlm.nih.gov/pubmed/37794437 http://dx.doi.org/10.1186/s13023-023-02916-x |
Ejemplares similares
-
Newborn Screening by Genomic Sequencing: Opportunities and Challenges
por: Bick, David, et al.
Publicado: (2022) -
Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH)
por: Taylor, Jane, et al.
Publicado: (2021) -
Correction to: Making the patient voice heard in a research consortium: experiences from an EU project (IMI-APPROACH)
por: Taylor, Jane, et al.
Publicado: (2022) -
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe
por: Garnier, Nicolas, et al.
Publicado: (2023) -
The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project
por: Teare, Harriet J. A., et al.
Publicado: (2018)